ACH
ACCENDRA HEALTH INC/VA/
NYSE · Healthcare · Medical - Distribution · US
$0.22
−6.30%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.24
From 52W high−96.00%
Volume4.56M
Market cap$16.93M
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 19, 2026
Open
$0.24
From 52W high
−96.00%
Volume
4.56M
Market cap
$16.93M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
7.8x
P/E (TTM)
—
RSI (14)
11.1
MomentumView details →
1D Return
−6.30%
YTD Return
−92.30%
Similar companies
Latest newsMore news →
The NYSE notified ACCENDRA HEALTH INC/VA/ that it was not in compliance with Section 802.01C because of its share price; the company said it would consider alternatives to regain compliance, including a reverse stock split subject to stockholder approval.10d agoAccendra Health Inc. announced that Kenneth Gardner-Smith will succeed Edward A. Pesicka as President and Chief Executive Officer effective October 5, 2026, with Pesicka retiring from the CEO and director roles and transitioning to an advisory consulting arrangement.21d agoAccendra Health Inc. appointed Kenneth Gardner-Smith as President and Chief Executive Officer, succeeding retiring Edward A. Pesicka, and named Scott Lloyd as Chief Commercial Officer effective October 5, 2026.32d ago